Cover Image

Evaluation of the effect of erenumab on migraine‐specific questionnaire in patients with chronic and episodic migraine

Abstract Erenumab is a fully human anti‐canonical calcitonin gene‐related peptide receptor monoclonal antibody approved for migraine prevention. The Migraine‐Specific Quality‐of‐Life Questionnaire (MSQ) is a 14‐item patient‐reported outcome instrument that measures the impact of migraine on health‐r...

Full description

Saved in:

Bibliographic Details
Main Authors:	Po‐Wei Chen (Author), Mats O. Karlsson (Author), Sebastian Ueckert (Author), Ari Pritchard‐Bell (Author), Cheng‐Pang Hsu (Author), Sandeep Dutta (Author), Malidi Ahamadi (Author)
Format:	Book
Published:	Wiley, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The course of headache after the end of treatment with erenumab in patients with episodic and chronic migraine
by: Anna A. Garmanova, et al.
Published: (2024)

Erenumab efficacy predictors for chronic migraine
by: Nina V. Vashchenko
Published: (2022)

Assessment and characteristics of Erenumab therapy on migraine management
by: Haitham Saeed, et al.
Published: (2022)

Predictors of clinical response to erenumab in patients with migraine
by: Olga Lekontseva, et al.
Published: (2022)

Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
by: De Matteis E, et al.
Published: (2022)

Identification of predictors of response to Erenumab in a cohort of patients with migraine
by: Houssein Salem-Abdou, et al.
Published: (2021)

Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
by: Shuchita Garg, et al.
Published: (2020)

Episodic Mydriasis as Migraine Equivalent
by: J Gordon Millichap
Published: (1991)

Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
by: Ronan Mahon, et al.
Published: (2024)

Migraine Episodes Following Cranial Irradiation
by: J Gordon Millichap
Published: (1995)

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
by: Francesca Schiano di Cola, et al.
Published: (2023)

Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open‐label, multiple‐dose study
by: Andrew D. Hershey, et al.
Published: (2024)

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study
by: Stewart J Tepper, et al.
Published: (2021)

Pediatric Episodic Migraine with Aura: A Unique Entity?
by: Hannah F.J. Shapiro, et al.
Published: (2021)

Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations
by: Cohen F, et al.
Published: (2022)

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine
by: Janet H. Ford, et al.
Published: (2023)

Efficacy and safety of galcanezumab for prevention of migraine headache in Japanese patients with episodic migraine: A phase 2 randomized controlled clinical trial
by: Fumihiko Sakai, et al.
Published: (2020)

Evaluating the wearing-off effects of fremanezumab in high-frequency episodic migraine and chronic migraine: A real-world observational study in Japan
by: Shiho Suzuki, et al.
Published: (2023)

Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine
by: Brian Baker, et al.
Published: (2020)

Migraine
Published: (2020)

The link between cutaneous allodynia and pain/sensitivity in teeth and gums during migraine episodes
by: Melis Yilmaz, et al.
Published: (2024)

Smartphone based music intervention in the treatment of episodic migraine headaches - A pilot trial
by: Guilhem Parlongue, et al.
Published: (2021)

Comorbidities of Rural Children and Adolescents with Migraine and without Migraine
by: Suzy Mascaro Walter, et al.
Published: (2023)

Prescribing of drugs for the treatment of migraine with specific emphasis on sumatriptan
by: Ilse Truter, et al.
Published: (2004)

Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR)
by: Ermioni Giannouli, et al.
Published: (2024)

Migraine A History
by: Foxhall, Katherine
Published: (2019)

Migraine A History
by: Foxhall, Katherine
Published: (2019)

Dry eye disease in episodic and chronic migraine: A cross-sectional clinic-based study
by: Bithi Chowdhury, et al.
Published: (2024)

The psychosocial impact of migraines on women and alternative therapies for migraine management
by: Ashalya Pirthiraj, et al.
Published: (2023)

Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update
by: Sergio Carmona, et al.
Published: (2009)

Migraine and Happiness
by: Heiko Pohl, et al.
Published: (2022)

Pediatric Migraine
by: Ubaid Hameed Shah, et al.
Published: (2009)

Somnambulism and Migraine
by: J Gordon Millichap
Published: (1987)

Menstrual Migraine
by: J Gordon Millichap
Published: (2004)

Acephalgic Migraine
by: J Gordon Millichap
Published: (1997)

Diet and Migraine
by: J Gordon Millichap
Published: (1987)

Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome
by: Rebecca M. Speck, et al.
Published: (2019)

Topiramate in Pediatric Migraine
by: J Gordon Millichap
Published: (2009)

Migraine-Related Stroke
by: J Gordon Millichap
Published: (1990)

Acute Confusional Migraine
by: J Gordon Millichap
Published: (1996)